Expressional Patterns of Chaperones in Ten Human Tumor Cell Lines
Overview
Affiliations
BACKGROUND: Chaperones (CH) play an important role in tumor biology but no systematic work on expressional patterns has been reported so far. The aim of the study was therefore to present an analytical method for the concomitant determination of several CH in human tumor cell lines, to generate expressional patterns in the individual cell lines and to search for tumor and non-tumor cell line specific CH expression.Human tumor cell lines of neuroblastoma, colorectal and adenocarcinoma of the ovary, osteosarcoma, rhabdomyosarcoma, malignant melanoma, lung, cervical and breast cancer, promyelocytic leukaemia were homogenised, proteins were separated on two-dimensional gel electrophoresis with in-gel digestion of proteins and MALDI-TOF/TOF analysis was carried out for the identification of CH. RESULTS: A series of CH was identified including the main CH groups as HSP90/HATPas_C, HSP70, Cpn60_TCP1, DnaJ, Thioredoxin, TPR, Pro_isomerase, HSP20, ERP29_C, KE2, Prefoldin, DUF704, BAG, GrpE and DcpS. CONCLUSIONS: The ten individual tumor cell lines showed different expression patterns, which are important for the design of CH studies in tumor cell lines. The results can serve as a reference map and form the basis of a concomitant determination of CH by a protein chemical rather than an immunochemical method, independent of antibody availability or specificity.
The impact of ERP29 on the progression of pharyngeal squamous cell carcinoma.
Carron J, Coser L, Lima C, Lourenco G Sci Rep. 2024; 14(1):25681.
PMID: 39465248 PMC: 11514305. DOI: 10.1038/s41598-024-76210-6.
CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status.
Zhang H, Zheng T, Qin C, Zhang X, Lin H, Huang X Cancer Gene Ther. 2024; 31(8):1151-1163.
PMID: 38997438 DOI: 10.1038/s41417-024-00806-3.
CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro.
Zeng W, Wu M, Cheng Y, Liu L, Han Y, Xie Q PLoS One. 2022; 17(12):e0279851.
PMID: 36584147 PMC: 9803215. DOI: 10.1371/journal.pone.0279851.
Yang X, Tong Y, Ye W, Chen L Mol Med Rep. 2022; 25(5).
PMID: 35315492 PMC: 8971898. DOI: 10.3892/mmr.2022.12690.
Ambrocio-Ortiz E, Perez-Rubio G, Ramirez-Venegas A, Hernandez-Zenteno R, Paredes-Lopez A, Sansores R Curr Issues Mol Biol. 2021; 43(2):887-899.
PMID: 34449539 PMC: 8928934. DOI: 10.3390/cimb43020063.